4/A//SEC Filing
Riddell Alastair 4/A
Accession 0001415889-19-000782
CIK 0001604191other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 8:01 PM ET
Size
5.4 KB
Accession
0001415889-19-000782
Insider Transaction Report
Form 4/AAmended
Riddell Alastair
Director
Transactions
- Award
Options
2019-06-13+30,000→ 30,000 totalExercise: $1.75Exp: 2024-06-13→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]Options will vest in quarterly installments over a one-year period beginning on June 30, 2019.
Documents
Issuer
AzurRx BioPharma, Inc.
CIK 0001604191
Entity typeother
Related Parties
1- filerCIK 0001681349
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 8:01 PM ET
- Size
- 5.4 KB